Advances in the treatment of atherosclerosis with ligand‐modified nanocarriers

Abstract Atherosclerosis, a chronic disease associated with metabolism, poses a significant risk to human well‐being. Currently, existing treatments for atherosclerosis lack sufficient efficiency, while the utilization of surface‐modified nanoparticles holds the potential to deliver highly effective...

Cijeli opis

Bibliografski detalji

Glavni autori:	Xiujiao Deng, Jinghao Wang, Shanshan Yu, Suiyi Tan, Tingting Yu, Qiaxin Xu, Nenghua Chen, Siqi Zhang, Ming‐Rong Zhang, Kuan Hu, Zeyu Xiao
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2024-06-01
Serija:	Exploration
Teme:	atherosclerosis drug delivery ligand‐modified nano‐drugs targeted therapies
Online pristup:	https://doi.org/10.1002/EXP.20230090
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!